Hyperpigmentation in MENA skin — a complete guide

Three main types — PIH, melasma, sun damage

Post-inflammatory hyperpigmentation (PIH) follows acne, eczema, contact dermatitis, ingrown hairs, or any inflammatory skin event. The melanocytes around the inflamed site upregulate pigment production and deposit it in the surrounding keratinocytes. The mark is sharply bordered, matches the shape of the original lesion, and lingers for weeks to months in lighter Fitzpatrick types and months to years in darker types (Davis EC, Callender VD, J Clin Aesthet Dermatol 2010).

Melasma is hormonally and UV driven. The classic distribution is symmetric on the cheeks, forehead, upper lip, and chin — the malar, centrofacial, and mandibular patterns. Pregnancy, oral contraceptives, and combined hormonal exposure trigger most cases; UV reactivates dormant melanocytes and turns a quiet condition into a visible one (Ortonne JP et al., J Eur Acad Dermatol Venereol 2009).

Solar lentigines (sun spots) are the cumulative-damage variant. Years of unprotected exposure leave discrete brown spots on the high-exposure zones — face, hands, forearms. Unlike PIH and melasma, lentigines do not resolve spontaneously; they require active treatment or laser to fade.

Why MENA skin is more prone to PIH

Fitzpatrick types III through V — the dominant phototypes across MENA — have larger, more melanin-producing melanocytes that respond more forcefully to inflammation and UV. Every spot, every ingrown hair, every cosmetic procedure carries a higher risk of leaving a brown mark behind.

Studies in Saudi Arabia, Egypt, and Lebanon report PIH as the chief acne-related complaint in 60 to 70% of adolescent and young adult patients (representative figures from regional dermatology cohort surveys, e.g. Al-Saif F et al., J Saudi Soc Dermatol 2018 and adjacent literature). The pattern repeats in eczema and post-procedure care: PIH is often the more visible, longer-lasting problem than the original condition.

The clinical implication is preventive. Treat the inflammation gently. Avoid aggressive procedures that cause inflammation in the first place. Layer pigment-protective ingredients prophylactically when starting an irritating active. SPF50 is non-negotiable.

The tyrosinase pathway — and the inhibitors that work

Pigment formation runs through tyrosinase, the rate-limiting enzyme that converts tyrosine to melanin precursors. Block tyrosinase, and pigment production drops. Several actives accomplish this with peer-reviewed evidence at cosmetic concentrations.

Tranexamic acid blocks the plasmin-driven pathway upstream of tyrosinase and reduces UV-induced melanocyte activation. Topical 2 to 5% over 8 to 12 weeks shows measurable reduction in melasma severity (Lee HC et al., Ann Dermatol 2016). Oral tranexamic acid is even more effective for refractory melasma but requires physician supervision.

Vitamin C (L-ascorbic acid at 10 to 20%, or stable derivatives like ethyl ascorbic acid at 5 to 10%) inhibits tyrosinase directly and offers complementary antioxidant protection that prevents new UV-driven pigment formation. Pair with vitamin E and ferulic acid for enhanced photoprotection (Lin FH et al., J Invest Dermatol 2005).

Alpha-arbutin is a beta-glucoside of hydroquinone, with the same tyrosinase-inhibiting mechanism but a far better safety profile and no exogenous-ochronosis risk. At 1 to 2% it is the conservative pigment-active for sensitive or pregnant patients (Polnikorn N, J Cosmet Laser Ther 2010).

Niacinamide blocks melanosome transfer downstream of tyrosinase. At 4 to 5% over 8 weeks, panel measurements show visible lightening of hyperpigmented spots without bleaching surrounding skin (Hakozaki T et al., Br J Dermatol 2002).

Azelaic acid combines tyrosinase modulation with anti-inflammatory action — useful when acne and PIH coexist. The 15 to 20% concentration tier handles both at once.

The non-negotiable role of SPF

Every pigment treatment fails without daily SPF50. UV reactivates melanocytes around treated sites within days. The single most evidence-based addition to a hyperpigmentation routine — more impactful than any tyrosinase inhibitor — is rigorous broad-spectrum SPF every morning, reapplied every two hours of direct exposure.

For melasma, visible-light protection matters too. Iron oxides in tinted sunscreens block the visible-light wavelengths that further activate dermal melanocytes. The BIOSAR Sunprotex BB Cream SPF50 layers iron oxides on the broad-spectrum filter system precisely for this reason.

Routine protocol — when to use which

Morning: gentle cleanser, vitamin C 10 to 15%, niacinamide 4 to 5%, broad-spectrum SPF50. The vitamin C acts as antioxidant and tyrosinase inhibitor. The niacinamide blocks melanosome transfer. The SPF prevents new damage.

Evening: gentle cleanser, alternate between tranexamic acid serum (or alpha-arbutin) and a retinol or AHA evening. Use the Whitepurity range for the dedicated pigment work; reserve retinol or AHAs for tone-and-texture nights. Always finish with a ceramide-led moisturiser.

Weekly: a gentle AHA peel at 5 to 10% glycolic or 5% mandelic acid accelerates the surface fade. Skip retinol on peel nights. Add the Acnemed Detoxifying Mask or the Serenvit Brightening Mask depending on whether acne or pigment is the primary concern.

BIOSAR Whitepurity range

The Whitepurity range is structured around the four-active pigment protocol. Whitepurity Brightening Cleanser opens the routine. Whitepurity Tranexamic Acid Serum delivers the upstream block at 3%. Whitepurity Alpha-Arbutin Cream stacks the tyrosinase inhibitor with niacinamide. Whitepurity SPF30 Tone-Up Cream finishes the morning with iron-oxide-tinted broad-spectrum protection.

For melasma specifically, layer the Serenvit Vitamin C Serum in the morning before the Whitepurity routine. For PIH from acne, run the Acnemed range for the active spots and the Whitepurity range for the marks they leave behind. The Sunprotex BB Cream SPF50 substitutes for any tinted SPF when melasma overlaps with daily sun exposure.

Frequently asked

How long until I see results?

PIH improves measurably between 8 and 12 weeks. Melasma is slower — expect 12 to 24 weeks for visible fade, and accept that maintenance is lifelong. Solar lentigines may need professional intervention (laser or focused chemical peels) for full resolution.

Can I use hydroquinone?

Hydroquinone at 2 to 4% is the most studied pigment active and remains the dermatology gold standard for short courses. It is prescription-only in most MENA markets and not appropriate for self-treatment. Long-term use risks exogenous ochronosis. Use only under physician supervision and never beyond 4 to 6 month courses.

Is melasma curable?

No. Melasma is a chronic relapsing condition. The realistic goal is suppression — fade visible pigment with active treatment, then maintain with daily SPF and a lower-intensity pigment-active routine. Stopping treatment usually means relapse within 3 to 6 months.

Can I treat hyperpigmentation during pregnancy?

Yes, with the pregnancy-acceptable list: niacinamide, vitamin C, alpha-arbutin, azelaic acid, and topical tranexamic acid (with physician approval). Avoid retinol, hydroquinone, and high-dose AHAs. SPF50 plus iron oxide tinted sunscreen is the most impactful single intervention during pregnancy melasma.